​

Sagimet Biosciences Ownership | Who Owns Sagimet Biosciences?

OverviewForecastFinancialsChart

Sagimet Biosciences Ownership Summary

Sagimet Biosciences is owned by 9.54% institutional investors, 5.93% insiders, and 84.53% retail investors. Woodline partners lp is the largest institutional shareholder, holding 4.66% of SGMT shares.

SGMT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSagimet Biosciences9.54%5.93%84.53%
SectorHealthcare Stocks 232.63%10.66%-143.29%
IndustryBiotech Stocks 382.12%10.42%-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Woodline partners lp1.50M4.66%$10.30M
Vanguard group1.26M3.88%$7.46M
Blue owl capital lp1.24M3.83%$7.36M
Baker bros. advisors lp953.00K2.96%$6.54M
Blackrock funding, inc. /de813.95K2.51%$4.82M
Hhlr advisors724.80K2.25%$4.97M
Siren724.77K2.25%$4.97M
Schonfeld strategic advisors523.77K1.63%$3.59M
Affinity asset advisors350.00K1.09%$2.40M
Renaissance342.50K1.05%$2.03M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp1.24M0.55%$7.36M
Fny investment advisers142.88K0.24%$845.00K
Affinity asset advisors350.00K0.21%$2.40M
Siren724.77K0.19%$4.97M
Hhlr advisors724.80K0.12%$4.97M
Rb capital management97.00K0.11%$574.24K
Readystate asset management lp325.36K0.10%$2.23M
Dumac71.19K0.06%$421.46M
Woodline partners lp1.50M0.05%$10.30M
Baker bros. advisors lp953.00K0.05%$6.54M

Top Buyers

HolderShares% AssetsChange
Schonfeld strategic advisors523.77K0.02%430.64K
Affinity asset advisors350.00K0.21%350.00K
Blackrock funding, inc. /de813.95K0.00%201.24K
Renaissance342.50K0.00%181.10K
Verition fund management154.67K0.00%154.67K

Top Sellers

HolderShares% AssetsChange
Nea management company---2.00M
Point72 asset management---1.76M
Alyeska investment group---1.19M
Woodline partners lp1.50M0.05%-1.05M
Rock springs capital management lp---787.81K

New Positions

HolderShares% AssetsChangeValue
Affinity asset advisors350.00K0.21%350.00K$2.40M
Verition fund management154.67K0.00%154.67K$915.65K
Rb capital management97.00K0.11%97.00K$574.24K
Dumac71.19K0.06%71.19K$421.46M
Graham capital management49.05K0.01%49.05K$336.49K

Sold Out

HolderChange
Advisor group-10.00
Hollencrest capital management-15.00
Farther finance advisors-39.00
Proffitt & goodson-175.00
Rise advisors-306.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202525-67.95%3,097,338-75.49%90.62%12-72.73%4-55.56%
Sep 30, 202521-69.12%1,885,710-83.19%50.48%8-77.78%2-77.78%
Jun 30, 202573-2.67%11,674,800-15.26%361.98%3815.15%11-38.89%
Mar 31, 20256-91.43%2,545,717-85.38%70.26%1-96.77%1-94.74%
Dec 31, 2024715.97%17,500,774-10.97%551.49%3239.13%19-17.39%

Recent Insider Transactions

DateNameRoleActivityValue
Feb 10, 2026Happel David President & CEOSell$64.86K
Feb 10, 2026Chauche Thierry Chief Financial OfficerSell$7.03K
Feb 10, 2026Martins Eduardo Bruno Chief Medical OfficerSell$19.51K
Feb 10, 2026Rozek Elizabeth Chief Legal & Admin. OfficerSell$14.05K
Nov 20, 2025Kemble George Executive ChairmanSell$289.98K

Insider Transactions Trends

DateBuySell
2026 Q1-4
2025 Q4-1
2025 Q3-3
2025 Q2--
2025 Q1--

SGMT Ownership FAQ

Who Owns Sagimet Biosciences?

Sagimet Biosciences shareholders are primarily institutional investors at 9.54%, followed by 5.93% insiders and 84.53% retail investors. The average institutional ownership in Sagimet Biosciences's industry, Biotech Stocks , is 382.12%, which Sagimet Biosciences falls below.

Who owns the most shares of Sagimet Biosciences?

Sagimet Biosciences’s largest shareholders are Woodline partners lp (1.5M shares, 4.66%), Vanguard group (1.26M shares, 3.88%), and Blue owl capital lp (1.24M shares, 3.83%). Together, they hold 12.37% of Sagimet Biosciences’s total shares outstanding.

Does Blackrock own Sagimet Biosciences?

BlackRock is not among the top 10 institutional shareholders of Sagimet Biosciences.

Who is Sagimet Biosciences’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Sagimet Biosciences’s biggest shareholder by percentage of total assets invested, with 0.55% of its assets in 1.24M Sagimet Biosciences shares, valued at 7.36M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools